The Scientific Outreach Gap

A survey finds that arts, humanities, and social science faculty members in the U.K. engage more with the general public than their counterparts in science, technology, engineering, and mathematics.

Written byBob Grant
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Are female scientists better about public outreach?WIKIMEDIA, UNITED STATES NAVYScience, technology, engineering, and mathematics (STEM) researchers do not engage in public outreach as much as academics in the arts, humanities, and social sciences (AHSS), according to a survey of faculty members in the U.K. What’s more, female researchers in both areas work with the general public more than their male counterparts, the study found. “The project suggests that public engagement is more firmly embedded in the context of the arts, humanities, and social sciences than it is among researchers in science, technology, engineering, and mathematics,” wrote the authors of the report, which was funded by a consortium of UK scientific societies and funders, including the Wellcome Trust. “Wide ranging research over a lengthy period shows that institutional change of this kind is highly challenging and that higher education institutions are known to be relatively slow to change.”

The authors surveyed more than 2,500 academics in the U.K., asking about the scholars’ efforts to communicate with the public. The survey tuned up several differences between AHSS and STEM researchers. For example, More than 60 percent of AHSS researchers indicated that they had lectured in a public forum in the past year, while only 40 percent of STEM researchers said they had done the same.

The more complicated nature of research in STEM fields may have something to do with the reduced public engagement, but that factor alone shouldn’t excuse researchers from discussing their work in wider forums, according to Chloe Sheppard, researchers’ engagement manager at the Wellcome Trust and chair of the steering group that directed the study. “I don’t think [this explanation] ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies